AT352876B - Verfahren zur herstellung von neuen 3- heterothiomethylureidocephalosporinen - Google Patents

Verfahren zur herstellung von neuen 3- heterothiomethylureidocephalosporinen

Info

Publication number
AT352876B
AT352876B AT155177A AT155177A AT352876B AT 352876 B AT352876 B AT 352876B AT 155177 A AT155177 A AT 155177A AT 155177 A AT155177 A AT 155177A AT 352876 B AT352876 B AT 352876B
Authority
AT
Austria
Prior art keywords
heterothiomethylureidocephalosporines
producing new
producing
new
Prior art date
Application number
AT155177A
Other languages
English (en)
Other versions
ATA155177A (de
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/664,795 external-priority patent/US4088815A/en
Priority claimed from US05/664,796 external-priority patent/US4088816A/en
Priority claimed from US05/764,134 external-priority patent/US4127716A/en
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of ATA155177A publication Critical patent/ATA155177A/de
Application granted granted Critical
Publication of AT352876B publication Critical patent/AT352876B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT155177A 1976-03-08 1977-03-08 Verfahren zur herstellung von neuen 3- heterothiomethylureidocephalosporinen AT352876B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/664,795 US4088815A (en) 1974-09-20 1976-03-08 3-Heterothio-7-ureido cephalosporins
US05/664,796 US4088816A (en) 1974-09-20 1976-03-08 3-Heterothio substituted 7-(ureido-heteroacetyl) cephalosporins
US05/764,134 US4127716A (en) 1976-03-08 1977-02-02 3-heterothiomethyl ureido cephalosporins

Publications (2)

Publication Number Publication Date
ATA155177A ATA155177A (de) 1979-03-15
AT352876B true AT352876B (de) 1979-10-10

Family

ID=27418117

Family Applications (1)

Application Number Title Priority Date Filing Date
AT155177A AT352876B (de) 1976-03-08 1977-03-08 Verfahren zur herstellung von neuen 3- heterothiomethylureidocephalosporinen

Country Status (16)

Country Link
JP (1) JPS52108996A (de)
AT (1) AT352876B (de)
AU (1) AU2236777A (de)
CA (1) CA1088517A (de)
CS (1) CS191190B2 (de)
DD (1) DD129793A5 (de)
DE (1) DE2707812A1 (de)
DK (1) DK97077A (de)
ES (1) ES456591A1 (de)
FR (1) FR2343745A2 (de)
GB (1) GB1573786A (de)
NL (1) NL7702405A (de)
NZ (1) NZ183332A (de)
PL (1) PL196501A1 (de)
PT (1) PT66272B (de)
SE (1) SE7702558L (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2927534A1 (de) * 1979-07-07 1981-01-08 Bayer Ag Optisch reine heterocyclische aminosaeuren, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
AU2236777A (en) 1978-08-24
PT66272B (fr) 1978-08-08
ATA155177A (de) 1979-03-15
DE2707812A1 (de) 1977-09-15
JPS52108996A (en) 1977-09-12
DD129793A5 (de) 1978-02-08
ES456591A1 (es) 1978-02-16
FR2343745A2 (fr) 1977-10-07
NL7702405A (nl) 1977-09-12
PT66272A (en) 1977-03-31
CA1088517A (en) 1980-10-28
NZ183332A (en) 1979-10-25
DK97077A (da) 1977-09-09
PL196501A1 (pl) 1978-02-13
SE7702558L (sv) 1977-09-09
GB1573786A (en) 1980-08-28
CS191190B2 (en) 1979-06-29

Similar Documents

Publication Publication Date Title
AT353959B (de) Verfahren zur herstellung von neuen 1- oxadethiacephalosporinen
AT351164B (de) Verfahren zur herstellung von neuen cephalos- porinderivaten
AT356827B (de) Verfahren zur herstellung von neuen spirol- actonen
AT358727B (de) Verfahren zur herstellung von neuen cephalos- porinantibiotika
AT356136B (de) Verfahren zur herstellung von neuen spiro- hydantoinen
AT359187B (de) Verfahren zur herstellung von neuen 7-beta-(2- -oxyimino-2-arylacetamido)-cephalosporinen
AT363478B (de) Verfahren zur herstellung von neuen oxepanderivaten
AT365611B (de) Verfahren zur herstellung von neuen 17alpha-(3-r2-oxypropyl)-17beta-r1-oxy-4-gonen-onen
ATA145077A (de) Verfahren zur herstellung von neuen ergolen- -derivaten
AT360185B (de) Verfahren zur herstellung von neuen dehydro- digopeptiden
AT353987B (de) Verfahren zur herstellung von neuen spirooxazolidindionen
AT362786B (de) Verfahren zur herstellung von neuen 1-acyl-2-imidazolinen
AT358726B (de) Verfahren zur herstellung von neuen cephalos- porinantibiotika
AT351191B (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT364364B (de) Verfahren zur herstellung von neuen thiepinen
AT375931B (de) Verfahren zur herstellung von neuen aminoalkylfuranderivaten
AT352876B (de) Verfahren zur herstellung von neuen 3- heterothiomethylureidocephalosporinen
ATA893377A (de) Verfahren zur herstellung von neuen thieno- thiazinderivaten
AT360646B (de) Verfahren zur herstellung von neuen cephalos- porinen
AT343623B (de) Verfahren zur herstellung von neuen n-alkyl -4-nitro-2- trifluormethyldiphenylaminen
ATA175879A (de) Verfahren zur herstellung von neuen antitumorglycosiden
ATA656076A (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT340054B (de) Verfahren zur herstellung von neuen 2-desoxystreptaminaminoglykosiden
ATA790678A (de) Verfahren zur herstellung von neuen cephalos- porinderivaten
AT355039B (de) Verfahren zur herstellung von neuen veraetherten hydroxy-benzimidazolonen, - benzoxazolonen, -benzoxazinonen,- china- zolinonen und -chinoxazolinonen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties